1. Home
  2. ACCO vs PHAT Comparison

ACCO vs PHAT Comparison

Compare ACCO & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACCO
  • PHAT
  • Stock Information
  • Founded
  • ACCO 1893
  • PHAT 2018
  • Country
  • ACCO United States
  • PHAT United States
  • Employees
  • ACCO N/A
  • PHAT N/A
  • Industry
  • ACCO Publishing
  • PHAT Biotechnology: Pharmaceutical Preparations
  • Sector
  • ACCO Consumer Discretionary
  • PHAT Health Care
  • Exchange
  • ACCO Nasdaq
  • PHAT Nasdaq
  • Market Cap
  • ACCO 410.0M
  • PHAT 339.8M
  • IPO Year
  • ACCO N/A
  • PHAT 2019
  • Fundamental
  • Price
  • ACCO $3.90
  • PHAT $4.10
  • Analyst Decision
  • ACCO Buy
  • PHAT Strong Buy
  • Analyst Count
  • ACCO 1
  • PHAT 5
  • Target Price
  • ACCO $7.00
  • PHAT $22.50
  • AVG Volume (30 Days)
  • ACCO 823.8K
  • PHAT 1.2M
  • Earning Date
  • ACCO 05-01-2025
  • PHAT 05-01-2025
  • Dividend Yield
  • ACCO 7.87%
  • PHAT N/A
  • EPS Growth
  • ACCO N/A
  • PHAT N/A
  • EPS
  • ACCO N/A
  • PHAT N/A
  • Revenue
  • ACCO $1,666,200,000.00
  • PHAT $55,252,000.00
  • Revenue This Year
  • ACCO N/A
  • PHAT $202.23
  • Revenue Next Year
  • ACCO $1.07
  • PHAT $113.81
  • P/E Ratio
  • ACCO N/A
  • PHAT N/A
  • Revenue Growth
  • ACCO N/A
  • PHAT 8001.47
  • 52 Week Low
  • ACCO $3.47
  • PHAT $3.81
  • 52 Week High
  • ACCO $6.44
  • PHAT $19.71
  • Technical
  • Relative Strength Index (RSI)
  • ACCO 46.59
  • PHAT 38.71
  • Support Level
  • ACCO $3.72
  • PHAT $3.81
  • Resistance Level
  • ACCO $3.94
  • PHAT $4.40
  • Average True Range (ATR)
  • ACCO 0.21
  • PHAT 0.48
  • MACD
  • ACCO 0.05
  • PHAT -0.05
  • Stochastic Oscillator
  • ACCO 85.80
  • PHAT 12.18

About ACCO Acco Brands Corporation

ACCO Brands Corp designs, manufactures, and markets consumer and business products. It operates through three segments: ACCO Brands North America, ACCO Brands EMEA, and ACCO Brands International. The company offers school notebooks, janitorial supplies, and whiteboards; storage and organization products, sheet protectors, and indexes, and punching products; computer accessories and others used in schools, homes, and businesses. It offers its products under the AT-A-GLANCE, Five Star, GBC, Hilroy, Kensington, Quartet, Leitz, NOBO and other brands. The company markets and sells its products through various channels, including mass retailers; e-tailers; discount, and variety chains; and warehouse clubs. It generates maximum profit from ACCO Brands North America segment.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: